Orsolya Toth

Summary

Country: Hungary

Publications

  1. ncbi request reprint In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters
    Orsolya Toth
    1st Department of Medicine, University of Pecs, Hungary, 13 Ifjúság út, Pecs, 7624 Hungary
    Life Sci 79:317-23. 2006
  2. ncbi request reprint Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood
    Orsolya Toth
    Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany
    Thromb Haemost 96:781-8. 2006
  3. ncbi request reprint Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques
    Sandra M Penz
    Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany
    Thromb Haemost 97:435-43. 2007
  4. pmc Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry
    Sandra M Penz
    Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany
    Thromb J 8:9. 2010
  5. ncbi request reprint Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women
    Barbara Réger
    Department of Laboratory Medicine, University of Pecs, Pecs, Hungary
    Thromb Res 131:e183-7. 2013

Collaborators

  • Hajna Losonczy
  • Wolfgang Siess
  • Hans Deckmyn
  • Sandra M Penz
  • Barbara Réger
  • Ilona Litter
  • Réka Mózes
  • Agnes Peterfalvi
  • Laszlo Poto
  • Gabor L Kovacs
  • Reinhard Lorenz
  • Isabell Bernlochner
  • Andreas Calatzis
  • Armin J Reininger
  • Richard Brandl

Detail Information

Publications5

  1. ncbi request reprint In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters
    Orsolya Toth
    1st Department of Medicine, University of Pecs, Hungary, 13 Ifjúság út, Pecs, 7624 Hungary
    Life Sci 79:317-23. 2006
    ..INO-1001 enhanced the effects of heparins above therapeutic ranges; the magnitude of this effect was negligible. Consequently, the PARP inhibitor INO-1001 can be safely applied together with the drugs tested...
  2. ncbi request reprint Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood
    Orsolya Toth
    Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany
    Thromb Haemost 96:781-8. 2006
    ..The use of hirudin as an anticoagulant is preferable to the use of citrate. MEA is a promising technique for experimental and clinical applications...
  3. ncbi request reprint Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques
    Sandra M Penz
    Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany
    Thromb Haemost 97:435-43. 2007
    ..Although these new anti-platelet agents inhibit platelet thrombus formation after plaque rupture, more efficient platelet blockers are required...
  4. pmc Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry
    Sandra M Penz
    Institute for Prevention of Cardiovascular Diseases, University of Munich, Munich, Germany
    Thromb J 8:9. 2010
    ....
  5. ncbi request reprint Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women
    Barbara Réger
    Department of Laboratory Medicine, University of Pecs, Pecs, Hungary
    Thromb Res 131:e183-7. 2013
    ..The aim of the study was to follow the changes of haemostatic parameters and to establish gestational age-specific reference intervals during normal pregnancy...